Menthol

Menthol

SCHEMBL3648445

CC1CCC(C(C)C)C(O)C1.OCCO

nearest known ligand 0.84

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TRPA1TRPM8

The experimentally established mechanism targets of Menthol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TRPM8 known ✓ Q7Z2W7 3/20 0.84
TRPA1 known ✓ O75762 2/20 0.84
EPHX1 P07099 3/20 0.46
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.36
OPRM1 P35372 1/20 0.35
KCNA5 P22460 1/20 0.35
TRPV1 Q8NER1 3/20 0.35
CYP19A1 P11511 2/20 0.35
KDM4E B2RXH2 1/20 0.35
APOBEC3A P31941 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Menthol SCHEMBL27906472 0.98 TRPM8 (0.81) TRPM8TRPA1EPHX1ALDH1A1LMNA
Menthol SCHEMBL20482244 0.96 TRPM8 (0.78) TRPM8TRPA1EPHX1ALDH1A1LMNA
Menthol SCHEMBL583696 0.93 TRPM8 (0.72) TRPM8TRPA1EPHX1ALDH1A1KCNA5
Levomenthol SCHEMBL2961481 0.93 TRPM8 (0.72) TRPM8TRPA1EPHX1ALDH1A1KCNA5
Menthol SCHEMBL28157641 0.92 TRPM8 (0.84) TRPM8TRPA1EPHX1ALDH1A1LMNA
Levomenthol SCHEMBL22227514 0.92 TRPM8 (0.84) TRPM8TRPA1EPHX1ALDH1A1LMNA
Menthol SCHEMBL4086460 0.92 TRPM8 (0.84) TRPM8TRPA1EPHX1ALDH1A1LMNA
Menthol SCHEMBL20771511 0.92 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1LMNA
(+)-Menthol SCHEMBL13059620 0.92 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1LMNA
(+)-Menthol SCHEMBL15449169 0.92 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118103737-A Contact lens 库博光学国际有限公司 2024-05-28 CN claimed
CN-218280602-U Menthol rectifying device 福建卫辰生物技术有限公司(CN) 2023-01-13 CN claimed
EP-1615974-B1 NON-TOXIC COATING COMPOSITION, METHODS OF USE THEREOF AND ARTICLES PROTECTED FROM ATTACHMENT OF BIOFOULING ORGANISMS SYMRISE GMBH & CO KG (DE) 2007-04-04 EP claimed
CN-118103737-A Contact lens 库博光学国际有限公司 2024-05-28 CN disclosed
EP-3585185-B1 METHOD FOR PRODUCING ROTUNDONE-CONTAINING MIXTURES SYMRISE AG (DE) 2024-04-10 EP disclosed
CN-116829015-A face mask 花王株式会社 2023-09-29 CN disclosed
EP-4247791-A2 NEW COOLANTS, AND PREPARATIONS CONTAINING SAME Symrise AG (DE) 2023-09-27 EP disclosed
WO-2023144326-A1 NEW COOLANTS, AND PREPARATIONS CONTAINING SAME SYMRISE AG (DE) 2023-08-03 WO disclosed
WO-2023143741-A1 NEW COOLANTS, AND PREPARATIONS CONTAINING SAME SYMRISE AG (DE) 2023-08-03 WO disclosed
WO-2022105986-A1 NOVEL COOLING AGENTS AND PREPARATIONS CONTAINING SAME SYMRISE AG (DE) 2022-05-27 WO disclosed
WO-2022106452-A2 NEW COOLANTS, AND PREPARATIONS CONTAINING SAME SYMRISE AG (DE) 2022-05-27 WO disclosed
WO-2018153499-A1 METHOD FOR PRODUCING ROTUNDONE-CONTAINING MIXTURES SYMRISE AG (DE) 2018-08-30 WO disclosed
US-20180055069-A1 PREPARATIONS SYMRISE AG (DE) 2018-03-01 US disclosed
US-20180049449-A1 PREPARATIONS SYMRISE AG (DE) 2018-02-22 US disclosed
US-20150313820-A1 PREPARATIONS SYMRISE AG (DE) 2015-11-05 US disclosed
US-20150094331-A1 QUINOLONE INHIBITORS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 AUSPEX PHARMACEUTICALS, INC. (US) 2015-04-02 US disclosed
EP-2187871-A1 MIXTURES COMPRISING PELLITORIN AND USES THEREOF Symrise GmbH & Co. KG (DE) 2010-05-26 EP disclosed
WO-2009021558-A1 MIXTURES COMPRISING PELLITORIN AND USES THEREOF SYMRISE GMBH & CO. KG (DE) 2009-02-19 WO disclosed
WO-2009021018-A1 FLAVOR SHEET FOR SMOKING ARTICLE LORILLARD LICENSING COMPANY, L.L.C. (US) 2009-02-12 WO disclosed
US-7087255-B2 Chewing gums that provide breath freshening characteristics WM. WRIGLEY JR. COMPANY (US) 2006-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150094331-A1 QUINOLONE INHIBITORS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 PLA2G12A, PLA2G4A, PLA2G2A TRPM8 3134/4885TRPA1 3507/4885EPHX1 213/4885
US-20180049449-A1 PREPARATIONS CRAT, ACAT2, TAS2R50 TRPM8 101/4885TRPA1 188/4885EPHX1 1451/4885
US-20180055069-A1 PREPARATIONS CRAT, ACAT2, TAS2R50 TRPM8 101/4885TRPA1 188/4885EPHX1 1451/4885
US-20150313820-A1 PREPARATIONS CRAT, ACAT2, TAS2R50 TRPM8 101/4885TRPA1 188/4885EPHX1 1451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.